Navigation Links
IDEXX Laboratories Announces Second Quarter Results
Date:7/24/2009

WESTBROOK, Maine, July 24 /PRNewswire-FirstCall/ -- IDEXX Laboratories, Inc. (Nasdaq: IDXX), today reported that revenues for the second quarter of 2009 were $265.7 million compared to $280.6 million for the second quarter of 2008. Organic revenue growth, as defined below, was 5%. Earnings per diluted share ("EPS") for the quarter ended June 30, 2009 were $0.55 compared to $0.63 for the same period in the prior year. Excluding incremental EPS that resulted from sales of pharmaceutical products that were subsequently divested or discontinued in 2008, EPS in the second quarter of 2008 would have been $0.54, and thus EPS growth without this contribution was 2%.

Organic revenue growth excludes the impact of changes in currency exchange rates, which reduced revenue growth by approximately 5%, and revenue from businesses acquired or divested subsequent to the beginning of the prior year period, including pharmaceutical products that were divested in the fourth quarter of 2008. Pharmaceutical revenues and related earnings in the second quarter of 2008 were exceptionally high due to the sale of the remaining inventory of PZI VET((R)) in connection with the discontinuation of that product.

"Our second quarter results reflect our continued focus on productivity in the current economic environment," said Jonathan Ayers, Chief Executive Officer. "Economic weakness reduced pet visits to U.S. veterinary clinics, our largest customer segment, by an estimated 4% year over year, similar to the first quarter of 2009. We nonetheless achieved 5% organic growth during the period. This growth was led by sales of our Catalyst Dx((R)) chemistry analyzers and consumables, which transitioned out of limited launch phase and into full commercialization in the second quarter, per our expectation. We are very pleased with customer adoption
'/>"/>

SOURCE IDEXX Laboratories, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22

Related medicine news :

1. IDEXX Laboratories to Release 2009 Second Quarter Financial Results
2. IDEXX Laboratories to Present at William Blair 29th Annual Growth Stock Conference
3. IDEXX Laboratories Announces First Quarter Results
4. IDEXX Laboratories to Release 2009 First Quarter Financial Results
5. IDEXX Laboratories Announces Fourth Quarter and Full Year Results
6. IDEXX Laboratories to Release 2008 Fourth Quarter and Full-Year Financial Results
7. IDEXX Laboratories Names William Brown Corporate Vice President
8. IDEXX Laboratories to Present at William Blair 28th Annual Growth Stock Conference
9. IDEXX Laboratories to Release 2008 First Quarter Financial Results
10. IDEXX Laboratories Announces Increase in Share Repurchase Program
11. IDEXX Laboratories Announces Fourth Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:body image body essence Exhibition Opens at University of Miami 2Health News:Diabetes and Cardiovascular Disease: Online Presentation Looks at the Complex Relationship of These Two Diseases in Light of Recent Studies 2Health News:Nile Therapeutics to Present at the 27th Annual J.P. Morgan Healthcare Conference 2Health News:After Founding Meeting in St. Louis ... Labor Unions Vow Stepped Up Pressure on Congress to Support 'Medicare for All' Approach to Healthcare Reform 2Health News:After Founding Meeting in St. Louis ... Labor Unions Vow Stepped Up Pressure on Congress to Support 'Medicare for All' Approach to Healthcare Reform 3Health News:H.R. 2, Bipartisan Children's Health Bill, Will Provide Coverage to 11 Million Children 2Health News:H.R. 2, Bipartisan Children's Health Bill, Will Provide Coverage to 11 Million Children 3Health News:H.R. 2, Bipartisan Children's Health Bill, Will Provide Coverage to 11 Million Children 4Health News:Walking Is Good for Blocked Leg Arteries 2
Breaking Medicine Technology:Circassia Raises GBP15 Million ($25 Million) in Oversubscribed Investment Round 2Boston Scientific Announces Pricing of $2 Billion of Senior Notes 2Boston Scientific Announces Pricing of $2 Billion of Senior Notes 3Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 2Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 3Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 4Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 5Motivation May Be at Root of ADHD 56464 1Motivation May Be at Root of ADHD 56464 2Motivation May Be at Root of ADHD 56464 3Study 3A Hairstylists can help identify older clients who need health services 56462 1Study 3A Hairstylists can help identify older clients who need health services 56462 2Study 3A Hairstylists can help identify older clients who need health services 56462 3Electrical circuit runs entirely off power in trees 9831 1Electrical circuit runs entirely off power in trees 9831 2Electrical circuit runs entirely off power in trees 9831 3